alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 31.1

SECTION 302 SARBANES OXLEY CERTIFICATION

I, David Duquette, certify that:

1. I have reviewed this quarterly report on Form 10-QSB of New Century
Companies, Inc;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the small business
issuer as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
small business issuer and have:

a) Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under my supervision, to ensure that
material information relating to the small business issuer, including its
consolidated subsidiaries, is made known to me by others within those entities,
particularly during the period in which this report is being prepared;

b) Omitted;

c) Evaluated the effectiveness of the small business issuer's disclosure
controls and procedures and presented in this report my conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the small business issuer's internal
control over financial reporting that occurred during the small business
issuer's most recent fiscal quarter that has materially affected, or is
reasonably likely to materially affect, the small business issuer's internal
control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over
financial reporting, to the small business issuer's auditors and the audit
committee of the small business issuer's board of directors (or persons
performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the small business issuer's ability to record,
process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the small business issuer's internal
control over financial reporting.


November 14, 2006                       /s/ David Duquette
                                        ----------------------------------------
                                        Name:  David Duquette
                                        Title: Chief Executive Officer and
                                               Chief Financial Officer
<PAGE>


                                                                    EXHIBIT 99.1

          CERTIFICATION PURSUANT TO 18 U.S.C. 1350, AS ADOPTED PURSUANT
                TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Ultrak, Inc. (the "Company") on Form
10-Q for the period ended September 30, 2002 as filed with the Securities and
Exchange Commission on the date hereof, I, Niklaus F. Zenger, Chief Executive
Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(a)  This Form 10-Q fully complies with the requirements of Section 13(a) or
     15(d) of the Securities Exchange Act of 1934; and

(b)  The information contained in the Form 10-Q fairly presents, in all material
     respects, the financial condition and results of operations of the Company.

/s/ Niklaus F. Zenger
---------------------------
Niklaus F. Zenger
Chief Executive Officer
November 19, 2002
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
financial statements as of and for the three months ended March 30, 1997 and is
qualified in its entirety by reference to such financial statements.
</LEGEND>
<MULTIPLIER>                                            1000
       
<S>                                                     <C>
<PERIOD-TYPE>                                           3-Mos
<FISCAL-YEAR-END>                                       DEC-28-1997
<PERIOD-START>                                          DEC-30-1996
<PERIOD-END>                                            MAR-30-1997
<CASH>                                                              3,557
<SECURITIES>                                                            0
<RECEIVABLES>                                                      47,598
<ALLOWANCES>                                                          405
<INVENTORY>                                                        32,770
<CURRENT-ASSETS>                                                  111,120
<PP&E>                                                            418,595
<DEPRECIATION>                                                    166,615
<TOTAL-ASSETS>                                                    765,334
<CURRENT-LIABILITIES>                                              68,789
<BONDS>                                                           529,749
<COMMON>                                                           12,055
<PREFERRED-MANDATORY>                                                   0
<PREFERRED>                                                             0
<OTHER-SE>                                                        (11,775)
<TOTAL-LIABILITY-AND-EQUITY>                                      765,334
<SALES>                                                           178,395
<TOTAL-REVENUES>                                                  178,395
<CGS>                                                              99,450
<TOTAL-COSTS>                                                      99,450
<OTHER-EXPENSES>                                                   69,249
<LOSS-PROVISION>                                                        0
<INTEREST-EXPENSE>                                                  9,124
<INCOME-PRETAX>                                                       165
<INCOME-TAX>                                                           61
<INCOME-CONTINUING>                                                   104
<DISCONTINUED>                                                          0
<EXTRAORDINARY>                                                         0
<CHANGES>                                                               0
<NET-INCOME>                                                          104
<EPS-PRIMARY>                                                        0.01
<EPS-DILUTED>                                                           0
                

</TABLE>
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 07-1425

CLYDE JOHNSON,

Plaintiff - Appellant,

versus

FEDERAL BUREAU OF INVESTIGATION, guns and

robbery narcotics department; ATF; U.S. DRUG

ENFORCEMENT AGENCY; STATE GOVERNMENT,

Defendants - Appellees.

Appeal from the United States District Court for the District of

Maryland, at Baltimore. William D. Quarles, Jr., District Judge.

(1:07-cv-00651-WDQ)

Submitted: September 11, 2007 Decided: September 13, 2007 

Before WILKINSON, MOTZ, and TRAXLER, Circuit Judges.

Affirmed by unpublished per curiam opinion.

Clyde Johnson, Appellant Pro Se.

Unpublished opinions are not binding precedent in this circuit.
- 2 -

PER CURIAM:

Clyde Johnson appeals the district court’s order

dismissing his complaint without prejudice for failure to state

a cognizable cause of action. We have reviewed the record and

find no reversible error. Accordingly, we affirm for the reasons

stated by the district court. Johnson v. FBI, No.

1:07-cv-00651-WDQ (D. Md. Mar. 23, 2007). We dispense with oral

argument because the facts and legal contentions are adequately

presented in the materials before the court and argument would not

aid the decisional process.

AFFIRMED
<TABLE> <S> <C>

<ARTICLE> 7
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               MAR-31-1999
<DEBT-HELD-FOR-SALE>                        28,129,196
<DEBT-CARRYING-VALUE>                       27,635,196
<DEBT-MARKET-VALUE>                         28,129,196
<EQUITIES>                                   5,117,245
<MORTGAGE>                                  13,709,351
<REAL-ESTATE>                                8,000,755
<TOTAL-INVEST>                             115,061,417
<CASH>                                       4,100,103
<RECOVER-REINSURE>                                   0
<DEFERRED-ACQUISITION>                      10,474,934
<TOTAL-ASSETS>                             201,625,754
<POLICY-LOSSES>                              1,408,663
<UNEARNED-PREMIUMS>                          2,294,690
<POLICY-OTHER>                               1,915,048
<POLICY-HOLDER-FUNDS>                      131,507,620
<NOTES-PAYABLE>                              3,345,573
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                    10,323,979
<OTHER-SE>                                  16,266,590
<TOTAL-LIABILITY-AND-EQUITY>               201,625,754
<PREMIUMS>                                   3,349,416
<INVESTMENT-INCOME>                          2,541,565
<INVESTMENT-GAINS>                             169,693
<OTHER-INCOME>                               5,493,940
<BENEFITS>                                   2,203,949
<UNDERWRITING-AMORTIZATION>                          0
<UNDERWRITING-OTHER>                                 0
<INCOME-PRETAX>                                 45,927
<INCOME-TAX>                                  (11,981)
<INCOME-CONTINUING>                             89,027
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    89,027
<EPS-PRIMARY>                                      .02
<EPS-DILUTED>                                      .02
<RESERVE-OPEN>                                       0
<PROVISION-CURRENT>                                  0
<PROVISION-PRIOR>                                    0
<PAYMENTS-CURRENT>                                   0
<PAYMENTS-PRIOR>                                     0
<RESERVE-CLOSE>                                      0
<CUMULATIVE-DEFICIENCY>                              0
        

</TABLE>
118TH CONGRESS 

1ST SESSION H. R. 2610 

AN ACT 

To amend the Securities Exchange Act of 1934 to specify 

certain registration statement contents for emerging 

growth companies, to permit issuers to file draft registration statements with the Securities and Exchange Commission for confidential review, and for other purposes. 
2 

•HR 2610 EH

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. REGISTRATION STATEMENTS. 

4 Section 12(b) of the Securities Exchange Act of 1934 

5 (15 U.S.C. 78l(b)) is amended— 

6 (1) in paragraph (1)(K), by striking ‘‘years,’’ 

7 and inserting ‘‘years (or, in the case of an emerging 

8 growth company, not more than the two preceding 

9 years),’’; and 

10 (2) by adding at the end the following: 

11 ‘‘Any issuer may confidentially submit to the Commission 

12 a draft registration statement for confidential nonpublic 

13 review by the staff of the Commission prior to public fil14 ing, provided that the initial confidential submission and 

15 all amendments thereto shall be publicly filed with the 

16 Commission not later than 10 days before listing on a na17 tional securities exchange. Notwithstanding any other pro18 vision of this title, the Commission shall not be compelled 

19 to disclose any information provided to or obtained by the 

20 Commission pursuant to this subsection. For purposes of 

21 section 552 of title 5, this subsection shall be considered 

22 a statute described in subsection (b)(3)(B) of such section 

23 552. Information described in or obtained pursuant to this 
3 

•HR 2610 EH

1 subsection shall be deemed to constitute confidential infor2 mation for purposes of section 24.’’. 

Passed the House of Representatives June 5, 2023. 

Attest: 

Clerk. 
118TH CONGRESS 

1ST SESSION H. R. 2610 

AN ACT 

To amend the Securities Exchange Act of 1934 to 

tial review, and for other purposes. curities and Exchange Commission for confidento file draft registration statements with the Sefor emerging growth companies, to permit issuers specify certain registration statement contents
Exhibit 31(ii)
                                 --------------


                                 CERTIFICATIONS
                                 --------------

   I, Steve Bailey, certify that:

             1.   I have reviewed this report on Form 10-K and all reports on
                  Form 10-D required to be filed in respect of the period
                  covered by this report on Form 10-K of Alternative Loan Trust
                  2007-6 (the "Exchange Act periodic reports");

             2.   Based on my knowledge, the Exchange Act periodic reports,
                  taken as a whole, do not contain any untrue statement of a
                  material fact or omit to state a material fact necessary to
                  make the statements made, in light of the circumstances under
                  which such statements were made, not misleading with respect
                  to the period covered by this report;

             3.   Based on my knowledge, all of the distribution, servicing and
                  other information required to be provided under Form 10-D for
                  the period covered by this report is included in the Exchange
                  Act periodic reports;

             4.   I am responsible for reviewing the activities performed by the
                  servicer(s) and based on my knowledge and the compliance
                  review(s) conducted in preparing the servicer compliance
                  statement(s) required in this report under Item 1123 of
                  Regulation AB, and except as disclosed in the Exchange Act
                  periodic reports, the servicer(s) have fulfilled their
                  obligations under the servicing agreement(s) in all material
                  respects; and

             5.   All of the reports on assessment of compliance with servicing
                  criteria for asset-backed securities and their related
                  attestation reports on assessment of compliance with servicing
                  criteria for asset-backed securities required to be included
                  in this report in accordance with Item 1122 of Regulation AB
                  and Exchange Act Rules 13a-18 and 15d-18 have been included as
                  an exhibit to this report, except as otherwise disclosed in
                  this report. Any material instances of noncompliance described
                  in such reports have been disclosed in this report on Form
                  10-K.

             In giving the certifications above, I have reasonably relied
             on information provided to me by the following unaffiliated
             parties: The Bank of New York, as Trustee, and Litton Loan
             Servicing LP.

    Date: March 26, 2008

          /s/ Steve Bailey
          -------------------------
          Steve Bailey
          Senior Managing Director, Chief Executive Officer Loan Administration
          (Senior officer in charge of the servicing function of
          Countrywide Home Loans Servicing LP)
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 99-7153

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

versus

LLOYD GEORGE MAXWELL,

Defendant - Appellant.

Appeal from the United States District Court for the Eastern District of Virginia, at Alexandria. Albert V. Bryan, Jr., Senior

District Judge. (CR-93-262)

Submitted: February 22, 2000 Decided: April 3, 2000

Before WIDENER and LUTTIG, Circuit Judges, and BUTZNER, Senior

Circuit Judge.

Affirmed as modified by unpublished per curiam opinion.

Lloyd George Maxwell, Appellant Pro Se. Thomas More Hollenhorst,

Assistant United States Attorney, Alexandria, Virginia, for

Appellee.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2

PER CURIAM:

Lloyd George Maxwell appeals the district court’s order denying his motion filed under 18 U.S.C. § 3582 (1994). Review of Maxwell’s petition reveals that it is more appropriately characterized

as a 28 U.S.C.A. § 2255 (West Supp. 1999) motion. Because Maxwell

has already filed at least one § 2255 motion, he may not file

another without first obtaining leave from this Court. Accordingly, we affirm the district court’s denial of Maxwell’s motion on

this alternative ground, and modify the judgment to reflect that

the denial is without prejudice to Maxwell’s right to move this

court for leave to file a successive § 2255 motion under 28

U.S.C.A. § 2244 (West Supp. 1999). We dispense with oral argument

because the facts and legal contentions are adequately presented in

the materials before the court and argument would not aid the decisional process.

AFFIRMED AS MODIFIED
#### Thomas R. HAMILTON, Petitioner, v. UNITED STATES POSTAL SERVICE, Respondent.

No. 00-3211.

United States Court of Appeals, Federal Circuit.

DECIDED: May 10, 2001.

Before MAYER, Chief Judge, SCHALL and GAJARSA, Circuit Judges.

*806ON MOTION

GAJARSA, Circuit Judge.

ORDER

Thomas J. Hamilton moves for a 60-day extension of time, until June 15, 2001, to file his brief.

Hamilton has already received four extensions of time totaling 242 days. On July 18, 2000, the court granted Hamilton’s motion for a 60-day extension of time to file his brief and obtain new counsel. On September 28, 2000, the court granted Hamilton’s second motion for a 60-day extension of time, cautioning that “no further extensions should be anticipated.” On December 15, 2000, the court granted Hamilton’s third motion for a 60-day extension of time and again warned that “no further extensions should be anticipated.” On February 20, 2001, the court granted Hamilton’s motion for a 62-day extension of time but explicitly stated that there would be “no further extensions.”

In apparent disregard of the court’s order, Hamilton seeks yet another extension of time. The language of the February 20, 2001 order was clear. The court will not grant any further extensions. Thus, the due date for Hamilton’s brief was April 16, 2001.

Accordingly,

IT IS ORDERED THAT:

> (1) The motion for an extension of time is denied.

> (2) Hamilton’s petition for review is dismissed for failure to file a brief.

> (3) Each side shall bear its own costs.
Exhibit
      10.49

    


    Named
      Executive Officer Compensation and Bonus Program

    


    The
      table
      below sets forth the base salaries of Sunesis Pharmaceuticals, Inc.’s, or
      Sunesis, Named Executive Officers, as approved by the Compensation
      Committee of the Board of Directors of Sunesis on January 26, 2007. The Named
      Executive Officers were determined in reference to Sunesis’ fiscal year ended
      December 31, 2006. Each of the Named Executive Officers’ employment with Sunesis
      is on an at-will basis. 

    


    


    
      	
              Name
                and Position

            	 	
              2007
                Base Salary($)

            	 
	
              Daniel
                N. Swisher, Jr

              Chief
                Executive Officer and President

            	 	 	
              390,000

            	 
	 	 	 	 	 
	
              Eric
                H. Bjerkholt

              Senior
                Vice President, Corporate Development and Finance,

              Chief
                Financial Officer

            	 	 	
              285,000

            	 
	 	 	 	 	 
	
              Daniel
                C. Adelman, M.D.

              Senior
                Vice President of Drug Discovery

            	 	 	
              300,000

            	 
	 	 	 	 	 
	
              James
                W. Young, Ph.D.

              Executive
                Chairman

            	 	 	
              200,000

            	 


    

    


    


    Each
      of
      the Named Executive Officers also participates in Sunesis’ bonus program in
      which the Company’s executive officers are eligible to receive an annual bonus
      based on a portion of their annual salary, or the Bonus Program. The Bonus
      Program is described more fully in Sunesis’ Proxy Statement for the 2007 Annual
      Meeting. Bonus targets are determined based on a review of peer group data
      for
      each Named Executive Officer’s position and level of responsibility and are
      reviewed annually. Actual bonus awards are determined by the Compensation
      Committee based on the level of achievement of corporate objectives set by
      the
      Board of Directors and individual payouts vary based on the relative
      contributions of the executive officers to the achievement of such objectives.
      For 2007, the Board of Directors has set the corporate objectives, but the
      Compensation Committee has not yet set the bonus targets for 2007. The Company’s
      other executive officers are also entitled to participate in the Bonus
      Program.
Exhibit 32.2





CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, 
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-QSB (the "Report") of Colorado Wyoming Reserve Company (the "Company") for the quarter ended December 31, 2003, I, Rafiq A. Sayed,, the Chief Financial Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of the undersigned's knowledge and belief:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Date:  June 29, 2005

/s/ Rafiq A. Sayed



Rafiq A. Sayed



Chief Financial Officer